GENTAMICIN(E) SULFATE: Solution bags may be leaking in affected lots.
Last updated
Summary
Product
GENTAMICIN(E) SULFATE
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
BAXTER |
GENTAMICIN(E) SULFATE |
DIN 02082152 |
Solution |
GENTAMICIN (GENTAMICIN SULFATE) 1.6 MG / ML |
W3G13C1 |
Issue
Solution bags may be leaking in affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Previous recalls or alerts
Background
Depth of recall: Wholesalers, Retailers, Healthcare Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Baxter Corporation.
7125 Mississauga Rd.,
Mississauga Ontario
Canada
L5N 0C2
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-74372
Get notified
Receive notifications for new and updated recalls and alerts by category.